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Abstract
This chapter is based in the compilation and analysis of different in vitro, 
preclinical, and clinical studies, which explored the potential beneficial bioactiv-
ity of supplementation with berries on some alterations in the central nervous 
system (CNS). The last section of the chapter describes the possible mechanisms 
of action of polyphenols, anthocyanins, and other compounds present in ber-
ries as well as their relationship with anxiety, depression, and Alzheimer’s (AD) 
and Parkinson’s diseases (PD) and their implication in the prevention of cogni-
tive decline and senescence motor functions. Electronic databases as Springer, 
PubMed, Scopus, and Elsevier were used. Papers were selected by topic specially 
those related with berries, year of publication, and authors. The present chapter 
evidenced the potential health effect as neuroprotector of different berries and 
their bioactive compounds mainly flavonoids, polyphenols, and anthocyanins, 
on diseases such as anxiety, depression, and Alzheimer’s and Parkinson’s dis-
eases. In conclusion, for human nutrition berry fruit supplementation might 
be an excellent source of antioxidant and alternative for prevention and reduc-
tion of symptoms in diseases such as anxiety, depression, Alzheimer’s, and 
Parkinson’s.
Keywords: berry, anthocyanins, polyphenols, neuroprotection, prevention
1. Introduction
Berries with a high antioxidant activity have drawn the attention of scientists 
due to their potential antioxidant, anticancer, anti-inflammatory, and neuropro-
tective-related effects, identified in in vivo studies [1]. It is well established that 
many species of berries, for example, strawberries (Fragaria ananassa), blueberries 
(Vaccinium corymbosum), raspberries (Rubus idaeus), and blackberries (Rubus 
fruticosus), are rich in bioactive compounds such as flavonoids, polyphenols, and 
anthocyanins. These compounds could be a supplementation alternative because 
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they are able to cross the blood-brain barrier and accumulate in various structures 
[2, 3] related to learning, memory, cognition process, and modification of behavior. 
In addition, their anti-neurodegenerative properties have been observed in diseases 
such as anxiety associated with stressful events [4] and reduction of depression, 
AD, and PD symptoms. Additionally, an association has been observed between 
the consumption of berries and increase in dendritic spine density in some brain 
structures and hippocampal neurogenesis [5]. In this way, the berry consumption 
and their bioactive compounds (i.e., polyphenols and anthocyanins) might be 
an excellent alternative for human nutrition when consumed fresh. They can be 
consumed as yogurt, juice, jam, or like dietary supplements that can be used as 
functional and nutraceutical foods.
Food is considered as a functional food if, in addition to its basic nutritional, 
it generates a beneficial effect in the physiological processes in the organism [6]. 
In the same way, a nutraceutical is a food or part of a food that produces health 
benefits besides its nutritional content [7, 8]. In the present chapter, we discuss the 
potential beneficial effects of berries and their derivatives on some central nervous 
system diseases.
2. Berries
Enhanced consumption of fruits and vegetables is highly recommended in 
dietary guidelines. Specially, the consumption of berries is recommended due to 
their antioxidant properties [1]. Berries, in botanical terms, are defined as fleshy 
fruits that emerge from the plant ovary that encloses the seeds; due to this, berries 
include grapes, blueberries, black currants, and coffee beans [9].
In this chapter we will focus on strawberries, blueberries, raspberries, 
chokeberries, black currants, and blackberries, among other endemic fruits. 
We selected these fruits because, in addition to being rich in polyphenols and 
anthocyanins, they are the most consumed in human diet; therefore, more 
studies related to their supplementation and chemical composition have been 
published.
Berries (i.e., blackberry, black raspberry, blueberry, cranberry, red raspberry, 
and strawberry) are popularly consumed either fresh, frozen, or processed as 
yogurts, beverages, jam and jellies, as well as dried or canned. Furthermore, berry 
extracts have been used as a functional food or dietary supplement [1].
Berries (blueberry, strawberry, blackberry, and Brazilian berries {Eugenia 
uniflora L.}) are considered an important group within functional foods, since 
multiple investigations have shown that their consumption produces beneficial 
health effects ranging from the mitigation of adverse physiological processes 
related to cardiovascular diseases and metabolic disorders to the amelioration 
of cognitive brain functions [10]. This highlights their ability to modulate neu-
roinflammation [11], glucoregulation [12], brain vascular function [13], and 
hippocampal neurogenesis [5]. These effects have been linked to their chemical 
compounds, specifically, to the presence of phenolic compounds in these fruits 
[14]. Table 1 shows specifically most consumed berries, their effect produced, and 
metabolite involved.
Even though the composition and the content of these compounds are 
dependent on the plant species, production status, agricultural processing, 
and storage, berries are an excellent source of polyphenols, flavonoids, and 
 anthocyanins [20, 21], which have been related to their potential beneficial 
effects on health.
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3. Active metabolites from berries with pharmacological activity
Berries are rich in phytochemicals such as minerals, vitamins, fatty acids, and 
dietary fibers and specifically contain provitamin A, minerals, vitamin C,  
and B complex vitamins. Additionally, fruits contain soluble solids, fructose, 
and chemopreventive agents as A, C, and E vitamins, folic acid, calcium, and 
selenium. Carotene and lutein are present in berries as well as phytosterols such 
as sitosterol and stigmasterol and also contain triterpene esters, and there is an 
excellent source of phenolic molecules such as flavonols, flavanols, proantho-
cyanidins, ellagitannins, phenolic acids, and anthocyanins specially cyanidin-
3-glucoside, gallic acid, pelargonidin, delphinidin, peonidin, and malvidin, 
among others [22].
The metabolism, bioavailability, and biological effects attributed to berries 
depend specifically on the type of chemical structure contained in its phenolic 
compounds that individually or synergistically exert protection against several 
health disorders [23]. Table 2 shows the main phytochemical compounds present in 
berries and their representative chemical structures.
Berry Effect Metabolite involved Ref
Blueberry (Vaccinium 
Virgatum A.)
Antioxidant Anthocyanins (1202 mg) [9]
Strawberry (Fragaria 
ananassa Duch.)
Antioxidant Polyphenols (13550 mg) [9]
Blackberry (Rubus 
sp.)
Antioxidant Anthocyanins (870 mg) [9]
Blueberry (*NS) Modulate 
neuroinflammation
Flavonoids: various 
concentrations of blueberry 
(50-500 μg)
[10]
Blueberry Highbush 
(Vaccinium 
corymbosum)
Glucoregulation Anthocyanins-flavonols (220 mg) [11]
Blueberry (Vaccinium 
corybosum)
Synaptic plasticity Anthocyanins (10.2 mg)/ Total 
phenolics (33 mg)
[12]
Blueberry (*NS) Hippocampal 
neurogenesis
Blueberry extract diet (20 g) (*NS 
anthocyanins or polyphenols)
[5]
Rasperry (Rubus 
idaeus)
Anti-cancer Anthocyanins (314 mg) [14]
Strawberry Beverage 
(*NS)
Anti-inflamatory/ 
hypoglycemic
Total phenols (94.7 mg)/ 
Anthocyanins (39 mg)
[15]
Grape (*NS) Genoprotective Anthocyanins (1576.5 mg)/ Total 
phenolics (2750.4 mg)
[16]
Blueberry Highbush 
(Vaccinium 
corymbosum)
Neuroprotection/
Proneurogenesis
Anthocyanins (4968·3 ng) [17]
Cranberry (Vaccinium 
oxycoccus)
Vascular Polyphenols (835 mg)/ 
Anthocyanins (94 mg)
[18]
Rabbiteye Blueberry 
(Vacciniumn ashei)
Motor and cognitive 
function Anxiolytic 
Genoprotective
Anthocyanins (2.6-3.2 mg) [19]
NS: not specified; Ref: reference
Table 1. 
Berries: effects and metabolites involved.
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3.1 Polyphenols
Polyphenols or phenolic compounds are phytochemicals that result from the 
secondary metabolism of plants coming from the metabolic pathway of shikimic acid 
and acetate-malonate. They are composed of various chemical structures character-
ized by an aromatic nucleus of benzene substituted by a hydroxyl group called phenol 
[21]. Differences between subclasses are given by the number of phenolic rings and the 
elements attached to them, thus creating several families of compounds, such as flavo-
noids, anthocyanins, flavones, tannins, and coumarins, among others [21, 27–29].
Polyphenols are present in fruits, vegetables, leaves, nuts, seeds, flowers, and 
barks [30] and act as inhibitors or activators for a wide variety of mammalian 
enzyme systems and as metal chelators and oxygen free radical scavengers [31, 
32]. Moreover, it has been reported that some flavonoids rise ion chlorine flow 
at the GABAA receptor in male rats [33, 34]. They can act as positive or negative 
Berry TP mg/100 g TA mg/100 g Characteristic 
structure
Ref
Blueberry (FW) 711.3 ± 360 ± 0.76 Gallic acid [22]
Blackberry 
(FW)
2611 104 Gallic acid [23]
Cranberry 
(DW)
59 117 Cyanidin 3-glucoside [24]
Raspberry
Black
Red
(FW)
267 
234.25
197.2 ± 3.5
68.17 ± 3.02
Cyanidin 3-glucoside [25]
Blackcurrant
(DW)
2382.4 ± 60.8 403.3 ± 11 Cyanidin 3-rutinoside [26]
Chemical structure was determined according to berry bioactive compound. TP: total polyphenols; TF: total flavonoids; 
TA: total anthocyanins; FW: fresh weight; DW: dry weight.
Table 2. 
Total polyphenols, anthocyanins and characteristic structure content of berries.
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modulators by direct actions on the effect of GABA [35, 36]. Considerable scientific 
evidence has shown that flavonoids are able to cross into the brain and influence 
brain function [37, 38]. They have a variety of effects like relief of anxiety, antide-
pressant actions, and neuroprotective [29] and sedative actions [39].
The ability of polyphenols to modulate the activity of different enzymes and con-
sequently interfere in signaling mechanisms and different cellular processes may be 
due, in part, to the physicochemical characteristics of these compounds, which allow 
them to participate in different oxide-reduction cellular metabolic reactions [40].
A diet rich in polyphenols has been shown to augment health [41]. It is best 
known for its biological effects in humans as anti-inflammatory [42] and anticar-
cinogenic [43]; in vitro as antiviral [44]; and in animals as gastroprotector [45] 
and antibacterial [46]; among others. More than 8000 phenolic compounds are 
known in nature [47], which according to their chemical composition are divided 
into 2 groups: phenolic acids (benzoic and cinnamic) and flavonoids (flavonoids, 
anthocyanins, and tannins) [48]. For the purposes of this chapter, we will focus on 
describing flavonoids in a general sense and anthocyanins in a particular manner.
3.2 Flavonoids
Their name derives from the Latin flavus, which means “yellow,” and constitutes 
the most abundant subclass of polyphenols within the vegetable kingdom [49]. 
They are low molecular weight compounds sharing a common diphenylpyrane 
skeleton (C6-C3-C6′), composed by two phenyl rings (A and B) bound through 
a heterocyclic pyran C ring. All flavonoids are hydroxylated structures in their 
aromatic rings and are therefore polyphenolic structures [41].
The main subgroups of flavonoid include flavonols, flavones, flavanones (dihydro-
flavones), isoflavones, and anthocyanins [50]. The flavonoid quercetin (4 mg/day) 
produces antineoplastic effects [51] and cholesterol-lowering effects in Japanese women 
aged 29–79 years old (9.3 ± 7.4 mg/day) [52], and at preclinical research in rats, querce-
tin (25 and 50 mg/kg) produces antithrombotic effects [53], while a hepatic regenera-
tive effect was detected with supplementations of silymarin (100 mg/kg/day) [54].
Among the most reported effects of flavonoids on the central nervous system 
are their participation in learning and memory mechanisms in Sprague Dawley rats 
supplemented with nobiletin (725 mg; extracted from Citrus depressa peels) [55]; 
in vitro aid in the treatment of AD by inhibiting the formation of plaques related to 
memory loss (myricetin, 1 mM) [56] and their neuroprotective role in PD (querce-
tin, 0.1 μM, or sesamin, 1 pM) [57]; and in male Swiss mice, antidepressant effect 
supplemented with Schinus molle L. (0.3–3 mg/kg) [58] and anxiolytic activities in 
Wistar rats (1 mg/kg of chrysin i.p.) and zebra fish (1 98 μL/0.1 g b.w.) [59].
3.3 Anthocyanins
Anthocyanins are an important group of water-soluble flavonoid compounds 
responsible for the red, purple, and blue colors in flowers, fruits, and other parts of 
plants that are not toxic for human consumption [48]. Their name derives from the 
Greek ανθός (anthos) meaning “flower” and κυανός (kyáneos) meaning “blue” [60].
They are polyhydroxy- or polymethoxy-glycosides derived from the basic struc-
ture, 2-phenyl benzopyryllium [61]. They consist of structures known as anthocy-
anidins or aglycones, which consist of an aromatic ring attached to a heterocyclic 
ring containing oxygen which, in turn, is linked to a third aromatic ring. When 
anthocyanidins are found in glucosylated form, they are then known as antho-
cyanins and are mainly accompanied by glucose, rhamnose, galactose, arabinose, 
xylose, and other disaccharides and trisaccharides [62]. These carbohydrates are 
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always bound to anthocyanidin position 3, and glucose is often found additionally 
in position 5 and, less commonly, in positions 7, 3′, and 4′ [63].
Anthocyanins are less water-soluble than when they are found in glucosinolates and 
rarely exist in free form in food. Today, about 19 natural anthocyanidins are known, 
although the most commonly found in foods are six: pelargonidin, delphinidin, cyani-
din, petunidin, peonidin, and malvidin [64], names derived from the plant source 
from which they were first isolated. In the same sense, a measure of the antioxidant 
capacity of anthocyanin pigments revealed that cyanidin-3-glucoside and delphinidin-
3-glucoside have the highest antioxidant activity [65] and have been identified in fruits 
coming from the berry family [66], specifically in blackberries [67, 68].
It is important to mention that anthocyanins resist passage through the digestive 
tract of mammals and are absorbed in the stomach and in the middle portion of the 
small intestine, reaching the bloodstream almost intact [69]; they reach organs such 
as the liver, eyes, and brain, thus accumulating in them [14, 70].
4. Biological effects
The biological functions of anthocyanins can be classified into two types: those 
related to their antioxidant capacity and those involved in the modulation of cell 
signaling pathways [71]. In general, they are attributed with effects such as the 
prevention and/or reduction of atherosclerosis [72]; reduction in the incidence of 
cardiovascular disease [73]; anticancer [74] and anti-inflammatory activity [75]; 
hypoglycemic effects [76]; and augmented visual acuity [77] and cognition [78].
Specifically, anthocyanins cross the blood-brain barrier and accumulate in brain 
regions related to learning and memory, such as the hippocampus and cerebral cor-
tex, modifying behavior [2]. It has been observed in in vitro studies that consump-
tion of these compounds inhibits the enzyme monoamine oxidase (MAO), in which 
increased activity is related to AD and other neurological disorders [79]. In addition, 
they display antioxidant capabilities, such as decreasing free radicals and stress 
signals controlling calcium homeostasis in the brain [80, 81], as well as the presence 
of hydrogen peroxide (H2O2) and radicals peroxide (ROO) and superoxide (O2) [82, 
83]. They also exert protective effects against oxidative stress in cellular models of 
PD [84] and promote optimal neurotransmission, primarily in advanced age [21].
It has also been observed that anthocyanins ameliorate anti-ocular-inflam-
matory in male Lewis rats supplemented with crude aronia extract (Aronia 
melanocarpa) in doses of 100 mg/kg, an effect similar to that found in ophthalmic 
prednisolone in a dose of 10 mg; this effect is evidenced by the direct blockage 
of the expression of the iNOS and COX-2 enzymes leading to suppression of NO, 
PGE2, and TNF-α production [85]. Another study in female Wistar rats ovariec-
tomized and supplemented with anthocyanin (200 mg/kg, 7 days of treatment) 
showed an augment in learning and memory in rats with estrogen deficiency caused 
by ovariectomy, showing lower errors and latency times in shuttle box test [86].
5. Berries and bioactive compounds on brain diseases
The recent increase in life expectancy worldwide has augmented the incidence of 
age-related diseases, particularly neurodegenerative diseases and psychiatric disorders.
Below, we will describe the effects of berry consumption and the relationship 
between diseases such as anxiety, depression, Alzheimer’s and Pasrkinson’s diseases, 
as well as human cognition, because those are the most common mental illness and 
neurodegenerative diseases [5].
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In addition, you will find in Table 3 the most recent research carried out related 
with supplementation in humans and in animal models and, additionally, study 
design and summarized findings.
5.1 Anxiety
Anxiety is a common and chronic psychiatric disorder that is a source of suf-
fering and impairment [96]. In 2017, the World Health Organization reported 
that more than 260 million people suffer from an anxiety disorder [97]. Its phar-
macological treatment is based on the use of benzodiazepine drugs, as well as 
some antidepressants with anxiolytic activity [98]. Unfortunately, these drugs are 
accompanied by severe side effects such as sedation, pharmacological tolerance, and 
drug dependence [99, 100]; in this sense, some patients complement their therapies 
with natural compounds coming from plants.
The study of the potential effect of berries on anxiety, due to their high content 
of polyphenols and anthocyanins associated with anxiolytic activity at the preclini-
cal level, has attracted important interest [101, 102]. It has been observed that these 
compounds, present in blueberries, have shown anxiolytic effects in animal models 
and their possible mechanisms of action are related to the antioxidant properties 
of anthocyanins [103] which inhibit the enzyme monoamine oxidases (MAOs), 
decreasing its activity and providing neuroprotection [77, 104].
Supplementation with blueberries in mice for 30 days has shown to increase the time 
spent in the open arms (anxiolytic effect) in the elevated plus maze test (EPM); in addi-
tion, it is shown to reduce oxidative damage to neural DNA, and this antioxidant neural 
protection has been proposed as a mechanism for the anxiolytic property of berries [19].
One of the most studied berries for anxiety at the preclinical level is the black 
chokeberry (Aronia melanocarpa) belonging to the Rosacea family [105], for 
example, in male Wistar rats, the acute administration of the juice at doses of 5 and 
10 ml/kg exerts dose-dependent anxiolytic activity in the social interaction test in a 
manner comparable to diazepam [102]. While, subchronic administration of Aronia 
melanocarpa fruit juice (10 ml/kg, orally) in male Wistar rats induces a time-depen-
dent anxiolytic effect [106]. Furthermore, the month-long unlimited consumption 
of black chokeberry juice (>20 ml/kg b.w daily) exerts reduction of anxiety-like 
behavior associated with MAO-A/MAO-B inhibitions [104], which is probably due 
to the high antioxidant activity that black chokeberry has shown to have [107].
On the other hand, this berry fruit has been evaluated in different concentra-
tions and behavioral tests such as the EPM and the social interaction test [102]. 
Likewise, a methanolic extract of blackberry (Rubus fruticosus) was used and 
reported an anxiolytic effect (100, 200, and 300 mg/kg, orally) in the hole-board 
test in a dose-dependent response [108]; also, the effect of Rubus brasiliensis fruits 
in Wistar rats has been studied, reporting an anxiolytic effect in EPM, in a dose of 
2.5 mg/kg administered per gavage [109]. In turn, an anxiety-related effect has been 
reported in treated male Swiss mice through supplemented water (2.6–3.2 mg/kg) 
per day of anthocyanins present in blueberry (Vaccinium ashei) [19].
Our working group [4] recently reported the anxiolytic effect from blackberry 
juice (doses intermediate: 5.83 mg/kg anthocyanins, 27.10 mg/kg polyphenols) on 
EPM in male Wistar rats, and the design was accompanied by the forced swim test 
(6 min). A decrease in the anxiety index was observed, without alterations in loco-
motor activity. This was similar to the group administered with the anxiolytic drug 
diazepam. Results revealed a better response to behavioral stress in the rats treated 
with blackberry juice, reinforcing the effects previously reported in EPM (Table 3).
The anxiolytic effect of some flavonoids and anthocyanins has been identified 
by affinity to GABAA receptors [89, 110]. However, its antioxidant capacity is still 
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Topic Author/
location
Study design Intervention Summarized findings
Anxiety Fernández-
Demeneghi 
et al.,  
2019 [4]/
Mexico 
n=45, 21 days treatment, Wistar male 
rats (200- 250 g)
Five groups were used: Veh (control group administered with 8.7 ml/kg), BL 
(low dose group of blackberry juice, 2.6 mg/kg of anthocyanins, 14.57 mg/
kg of polyphenols) BM (medium dose group of blackberry juice, 5.83 mg/
kg anthocyanins, 27.10 mg/kg polyphenols) BH (high-dose blackberry juice 
group 10.57 mg/kg anthocyanins, 38.4 mg/kg polyphenols) DZP (diazepam 
group administered 2 mg/kg).
The intermediate dose of blackberry juice (5.83 mg/kg of 
anthocyanins, 27.10 mg / kg of polyphenols) had an anxiolytic 
effect similar to DZP, improving coping strategies at the 
behavioral level. These results were supplemented by the forced 
swim test, where medium and high doses improved the response 
to acute stress. 
Depre ssion Chang  
et al., 
2016 [85]/
USA-UK
n=82643 women. Prospectively, the 
study examined the associations between 
the estimated usual intake of flavonoids 
in the diet and the risk of depression. 
Semiquantitative food frequency 
questionnaire was applied (FFQ).
Two samples were used: Nurses' Health Study (NHSI) (from 1976 nurses 
aged 30-55) and NHSII (from 1989 nurses aged 25-42).
Higher flavonoid intakes may be associated with lower 
depression risk, particularly among older women.
Khalid et 
al., 2017 
[86]/United 
Kingdom
n=21 university students (18-21 years)/
The Positive and Negative Affect 
Schedule-NOW (PANAS-NOW) was 
used to assess current mood.
Two groups were used: The flavonoid-rich wild blueberry (WBB), 
which administered 253 mg of anthocyanins, a combination of 30 g of 
lyophilized WBB, 30 ml of Rocks Orange Squash and 220 ml of water), 
placebo (4 mg of WBB, 30 ml of Rocks Orange Squash and 220 ml of 
water were combined).
In both studies, an increase in positive affection was observed 
after 2 hours of consumption of the WBB drink. Flavonoid 
supplementation can play a key role in promoting positive mood 
and are a possible way to prevent dysphoria and depression.
n=50 children (7-10)/child version of 
the Positive and Negative Affect Scale 
(PANAS-C).
Two groups were used: The flavonoid-rich wild blueberry (WBB) 253 mg 
anthocyanins, combination of 30 g lyophilized WBB, 30 ml Rocks Orange 
Squash and 170 ml water); placebo (4 mg WBB, 30 ml Rocks Orange 
Squash and 170 ml water were combined).
Nabavi  
et al., 2018 
[87]/Iran 
n=40, 7 days treatment, balb/c strain 
mice (5 weeks old, 20-25 g).
Four groups were used: control (healthy group), BCCAO (group with 
bilateral occlusion of the common carotid artery) 10 mg/kg (group with 
lesion + 10 mg/kg of aqueous extract of red berries of H. Androsaemum 
(WE) 30 mg/kg (group with lesion + 30 mg/kg of WE).
The protective effects of WE in post-stroke depression in 
a mouse model were demonstrated in vivo, both groups 
administered with WE reduced immobility time in forced swim 
and tail suspension tests. These findings are correlated with the 
antioxidant capacity of its bioactive constituents. 
Di Lorenzo 
et al, 2019 
[88]/Italy
n=50, 7 days treatment i.p., balb/c 
strain mice (2 weeks old, 20-25 g).
Five groups were used: 1) control: healthy group, 2) BCCAO (group with 
stroke common carotid artery bilateral occlusion), 3) 25 mg/kg (lesion + 
25 mg/kg Maqui berry extract (MBE)), 4) 50 mg/kg (lesion + 50 mg/kg 
MBE), 5) 100 mg/kg (lesion + 100 mg/kg MBE).
The results showed that the antidepressant-like activity provided 
by the extract, which was found to restore normal mouse behavior 
in both despair swimming and tail suspension tests, could be 
linked to its antioxidant activity, leading to the conclusion that 
maqui berries might be useful for supporting pharmacological 
therapy of Post-stroke depression by modulating oxidative stress. 
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Alzheimer’s 
disease
Gutierres 
et al., 2014 
[89]/Brazil
Male Wistar rats (3-months-1-year-old, 
350-400g), 7 days of treatment with 200 
mg/kg anthocyanin (ANT) the rats were 
injected with intracerebroventricular 
streptozotocin (3 mg/kg) (STZ), and 
four days later the behavior parameters 
were performed.
Four different groups: control (CTRL), anthocyanin (ANT), 
streptozotocin (STZ) and streptozotocin + anthocyanin (STZ + ANT).
A memory deficit was found in the STZ group, but ANT 
treatment showed that it prevents this impairment of memory. 
This work demonstrated that anthocyanin is able to regulate 
ion pump activity and cholinergic neurotransmission, as well 
as being able to enhance memory and act as an anxiolytic 
compound in animals with sporadic dementia of Alzheimer's 
type.
McNamara 
et al, 2018 
[90] / USA
n=76, 24 weeks treatment, study 
conducted in men and women aged 
62-80 with cognitive impairment. They 
used the Dysexecutive Questionnaire.
Four groups were used: FO (fish oil + placebo powder), BB (blueberry 
[Vaccinium sp] powder + placebo oil), FO+BB (fish oil + cranberry 
powder), PL (oil + placebo powder). Fish oil (400 mg EPA (1.6 g) and 
200 mg DHA (0.8 g)) and cranberry powder (phenolic concentration 
(20.4±0.31), anthocyanins (14.5±0.04)).
It was demonstrated that supplementation with FO and BB 
showed a reduction of self-reported inefficiencies in daily 
operation, by the BB group showed less interference in memory. 
Parkinson’s 
Disease
Fan et al., 
2018 [91] 
/ New 
Zealand
n= 11 male patients with Parkinson’s 
disease and older than 40 years old. 
2 sessions where samples of plasma 
and cerebrospinal fluid (CSF) were 
taken (in both sessions a 12-hour low 
anthocyanin diet was requested before 
taking the samples).
Study of pre and post treatment samples, where patients were 
supplemented with 300 mg blackcurrant capsules (35% anthocyanins, 
Super Currantex® 20) twice daily for four weeks.
The neuropeptide cyclic glycine protein (cGP), a natural BCA 
nutrient, was shown to be effectively absorbed in the brain after 
supplementation. The increase of cyclic glycine proline (cGP) in 
plasma and cephalorachidian fluid in Parkison patients is mainly 
due to central uptake of the neuropeptide in plasma. Thus, the 
role of insulin-like growth factor 1 (IGF-1) improves in patients 
with Parkinson’s disease.
Qian et al., 
2019 [92] / 
China 
n=45, 3 weeks treatment, 6-week old 
male C57BL/6 mice (18-22 g). This 
study was designed to investigate the 
effects of the ANC rich blueberry 
extracts (BBE) on behavior and 
oxidative stress in the mouse model 
of PD induced by 1- methyl-4-
phenyl-1,2,3,6- tetrahydropyridine 
(MPTP).
Five groups were used: 1) control (received i.p. saline), 2) MPTP 
(received i.p. MPTP 30 mg/kg for 5 days and saline, 3)BBE 50 mg/
kg (received i.p. MPTP 30 mg/kg for 5 days and 50 mg/kg blueberry 
extract (BBE), 4) BBE 100 mg/kg (received i.p. MPTP 30 mg/kg for 
5 days and 100 mg/kg of BBE) and 5) i.p MPTP and fed daily with 
levodopa and benserazide (10 mg/kg/day).
BBE improved motor function in MPTP- induced Parkinson's 
mice through a possible mechanism of their antioxidant 
capacity to eliminate free radicals and reduce oxidative damage 
to neurons.
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Topic Author/
location
Study design Intervention Summarized findings
Other 
effects
Devore  
et al., 2012 
[93]/USA
n=16,010 women, aged ≥70; follow-up 
assessments were conducted twice, at 
two-year intervals.
Follow-up questionnaire on eating habits (2-year period) and 
assessment of congenital impairment. Six cognitive tests were 
administered: Telephone Interview of Cognitive Status, a telephone 
adaptation of the Mini-Mental State Examination; East Boston Memory 
Test – immediate and delayed recalls; category fluency; delayed recall 
of the Telephone Interview of Cognitive Status 10- word list; and 
backwards digit span.
Increased consumption of berries and anthocyanidins, as well 
as total flavonoids, was shown to be associated with slower 
progression of cognitive impairment in older women.
Watson et 
al., 2015 
[94]/New 
Zealand   
n=36 healthy, young participants 
(18-35 years). The battery used was 
formed: digit vigilance, stroop, rapid 
visual information processing (RVIP) 
and logical reasoning.
Three intervention drinks were used: 1. control (containing 0 mg 
polyphenols), 2. Blackadder (7.78 mg/kg anthocyanins from an extract 
of Ribes nigrum). 3. DelCyan (trademark) (8.05 mg/kg anthocyanins 
from a blackcurrant extract).
It was demonstrated that the consumption of drinks 
supplemented with blackcurrants produce a cognitive benefit 
in healthy young people, evidenced by greater accuracy in the 
RIVP test; likewise, Blackadder improved reaction times in 
the task of monitoring digits. Clinically significant inhibition 
of monoamine oxidase-B and monoamine oxidase-A was 
identified using a commonly consumed fruit.
Whyte & 
Williams 
(2015) 
[95]/United 
Kingdom
n=16 children (8-10 years), 7 days 
of treatment. Two hours after 
consumption, the children completed 
a battery of five cognitive tests 
comprising the Go-NoGo, Stroop, Rey’s 
Auditory Verbal Learning Task, Object 
Location Task, and a Visual N-back.
Two intervention drinks were used: 1. blueberry (prepared by mixing 
200 g of Star variety blueberries with 100 ml, which contained 143 mg 
of anthocyanins). Control (combined with blueberry drink for sugars 
and vitamin C by adding 0.02 g of vitamin C powder, 8.22 g of sucrose, 
9.76 g of glucose and 9.94 g of fructose to 100 ml of semi-skimmed 
milk).
It was identified that anthocyanins (143 mg) present in 
blueberry juice have memory benefits in children aged 8 to 
10 years, however, little evidence in attention, visuospatial, 
working memory were observed.
Table 3. 
Recent research in humans and animal models related to supplementation with berries.
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considered the main mechanism of action [106], since oxidative stress has been 
proposed as an important contributor to anxiety generation [79].
5.2 Depression
Depression is the most prevalent psychiatric disorder; according to the World 
Health Organization, it affects 300 million people worldwide [97]. Depressive 
disorders are characterized by the presence of a sad and irritable mood accompa-
nied by somatic and cognitive changes that negatively impact everyday life function 
[97] and result in high financial costs [111]. A great variety of drugs exist for its 
treatment [112], in which therapeutic effects are driven by actions on diverse neu-
rotransmission systems (serotonergic, dopaminergic, and noradrenergic), exerting 
long-term changes which can restore neuronal function, for example, restoration of 
basal levels of neurotransmitters mainly serotonin, increase in neurotrophic factors 
(brain-derived neurotrophic factor and nerve growth factor) that can indirectly 
modify neuronal microarchitecture, reduction of oxidative stress, as well as neuro-
inflammation processes in structures related to the pathophysiology of depression 
which can impact at the affective level exerting favorable effects on the quality of 
life of the subjects. These drugs include tricyclic antidepressants (i.e., imipramine), 
selective serotonin recapture inhibitors (i.e., fluoxetine), monoamine oxidase 
inhibitors (phenelzine), and dual antidrepressant drugs (venlafaxine), among 
others [113]. Most of these drugs have a late onset and are often accompanied by 
side effects when taken for prolonged periods. This has encouraged a search for new 
substances with potential antidepressant effects and, most importantly, the use of 
possible natural alternatives.
An association between the role the hippocampus and the etiology of depression 
has been suggested, given that a reduction in hippocampal neurogenesis has been 
observed in depressed patients with respect to the non-depressed control group, 
which is accompanied by a decrease in the hippocampal volume [114]. In this sense, 
antidepressants such as fluoxetine have been shown to ameliorate neurogenesis in 
the hippocampus [115].
At the preclinical level, the administration of Aronia melanocarpa juice showed 
a decrease in total immobility time in the forced swimming test [107], similar to 
animals treated with imipramine. In addition, the study was supplemented with 
in vitro testing, where inhibition of the enzyme monoamine oxidase was observed, 
both in its A form and to a lesser extent in its B form [104]. MAO-A and MAO-B 
inhibitors are used clinically for the treatment of psychiatric and neurological 
disorders, respectively [116]. This activity has been proposed as another mechanism 
for the action of berries in mental disorders, as it is related to increased levels of 
serotonin, dopamine, and noradrenaline.
In addition, human studies related to blueberry and red berry supplementation have 
shown that a higher intake of these foods is associated with a lower risk of depression 
[85, 86]. Similarly, studies in mice have shown similar effects with the consumption of 
red berries, observing a reduction in depressive-like behaviors [87, 88] (Table 3).
5.3 Alzheimer’s disease
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by 
progressive memory loss, as well as cognitive decline [117] in which prevalence aug-
ments with age [118]. The neuropathologic changes underlying AD include senile 
plaques formed by the peptide β-amyloid and neurofibrillary tangles composed of 
hyperphosphorylated Tau protein that promotes synaptic dysfunction and neuronal 
death early and consistently [119].
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Oxidative stress has been associated with the onset and progression of AD [120]. 
This is supported by the high vulnerability of neurons to reactive oxygen species (ROS) 
[121]. Oxidative stress can induce damage to membrane lipids, changes in glial and neu-
ronal function, structural damage to DNA, synaptic dysfunction, and apoptosis [122].
Several studies have demonstrated the potential protective effect of blackberry 
fruits (Rubus L. subgenus Rubus Watson), in the prevention of age-related neuro-
degenerative disorders [123], specifically with PD. Berry fruits such as blackberry, 
black raspberry, blueberry, and strawberry are good sources of phytochemicals that 
provide protection against neurological disorders [93].
Extracts of black currant have been shown to inhibit the formation and spread of 
β-amyloid [124] and ROS fibrils. Supplementation of blackberry in in vitro studies 
has been reported to exhibit potent anti-inflammatory and antiproliferative proper-
ties [125, 126]; also, the consumption of blueberries is related to neuronal augment 
in the hippocampus [5].
Recently a neuroprotective effect of anthocyanins has been observed in a model 
of AD induced by streptozotocin that resulted in a cognitive deficit (in short-term 
memory and spatial memory), as well as dysfunction in the activity of the enzyme 
acetylcholinesterase, while inducing lipid peroxidation and a decrease in antioxidant 
enzymes in the cerebral cortex [127]. These alterations were attenuated in the group 
administered with anthocyanins. Similarly, it has been observed that blueberry powder 
(Vaccinium sp.) supplementation in patients with Alzheimer’s disease and cognitive 
decline reduces the self-reported inefficiencies in daily functioning [90] (Table 3).
5.4 Parkinson’s disease
Parkinson’s disease (PD) is characterized by tremors, stiffness, and akinesia. It is 
caused by the progressive degeneration of dopaminergic neurons in the substantia 
nigra and the presence of Lewy bodies. Many Parkinson’s risks and preventive 
factors have been investigated. The onset of this disorder has been associated with 
exposure to certain pesticides and heavy metals [128], tobacco consumption [129], 
and coffee consumption [130], among other environmental factors. While current 
treatments have shown effectiveness in early management of the motor symptoms 
of the disease [131] and both surgery and deep brain stimulation are useful, PD is 
currently not yet curable [132]. A diet enriched in phenolic compounds has been 
shown to have some efficacy in relieving Parkinson’s symptoms [133]. Most of the 
studies related to fruit consumption and disease focus on supplementation with 
blueberries, strawberries, black currant, and grapes, due to their powerful antioxi-
dant effects related to their high content of polyphenols and anthocyanins [134].
Cell models have reinforced studies of neurodegenerative disorders, recently 
demonstrating that anthocyanins from grape seed, blueberry, and mulberry enhance 
mitochondrial function [135] and suppressed dopaminergic cell death caused by 
rotenone (insecticide and pesticide) in mitochondrial respiration. This has suggested 
that anthocyanins may alleviate neurodegeneration in PD by improving mitochondrial 
function. In addition, polyphenols are able to ameliorate inflammatory responses 
associated with glial activation [136]. Phenolic compounds are known for their ability 
to eliminate reactive oxygen species (ROS) due to their antioxidant action; however, 
since their concentrations in the brain are lower than those of endogenous antioxi-
dants, it has begun to be seen that they also exert their neuroprotective effects through 
additional mechanisms [137, 138], highlighting the inhibition of MAO, in its two 
forms, A and B [77, 104]. At the preclinical level, one of the most widely used models 
in PD research is the administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 
(MPTP), a neurotoxin that causes a severe Parkinson’s-like syndrome in humans, 
monkeys, and mice [139–142]. It has been observed that daily administration of 
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resveratrol (red wine polyphenol) in male mice C57BL/6 prevented a decrease in striatal 
dopamine and maintained striatal tyrosine hydroxylase levels. In addition, mice that 
received resveratrol as pretreatment showed a greater number of immunopositive 
tyrosine hydroxylase neurons, indicating the protective role of resveratrol over nigral 
neurons [143]. In the same disease model, it was observed that blueberry extract 
attenuated behavioral impairment (motor coordination) as well as decreased levels of 
malondialdehyde in the brains of mice [92]. These data reveal the ability of resveratrol 
and polyphenols present in blueberry extract to counteract the toxic effects of MPTP 
administration and in the near future may be used as a complementary neuroprotective 
therapy (Table 3). Current PD therapies act by controlling the disease’s symptoms, but 
do not slow the underlying neurodegeneration in the brains of PD in patients [135]; this 
is an opportunity to use functional foods as adjuvant therapy in the presence of disease.
5.5 Human cognition
Polyphenols present in berries have also been associated with cognitive amelio-
ration and neuronal function, as is the case with grape juice, which in both young 
[144] and older adults [145] ameliorate neurocognitive functions of memory, atten-
tion, and calmness, compared to the placebo group. In this same regard, in mothers 
(40–50 years) of preadolescent children, an association of grape juice consumption 
has been observed (≥30 h/week 355 ml, during 12 weeks) with subtle augment in 
immediate spatial memory and safer driving behavior in a virtual simulator [146]. 
At the same time, it was found that, in a double-blind crossover design of children 
(7 and 10 years old), supplementation of 15 or 30 g freeze-dried wild blueberry 
powder significantly ameliorates word acquisition and recognition, as well as the 
ability to overcome the effects of response interference [147].
In a pilot study in healthy young adults in both genders (18–35 years old), it has 
been observed that the acute administration of black currant juice (500 mg/day of 
polyphenols, supplemented only 1 day per week, during 31 days) exerts an anxio-
lytic-like effect, as well as ameliorates alertness, less fatigue, and reaction speed [94].
In a randomized, double-blind placebo-controlled trial, dietary blueberry of 
24 g/day for 3 months raised the cognition in tests of executive function in adults 
between 60 and 75 years old of both sexes by increasing accuracy during task 
switching and reduced repetition errors during word-list recall [148]. The positive 
effects on cognition have been related to activation of the prefrontal cortex using 
functional magnetic resonance imaging [149]; therefore, the administration of blue-
berry to have the same effects on these tasks could be exercising greater activation 
of this structure to raise cognition. Another study found that daily consumption of 6 
and 9 ml/kg for 12 weeks of blueberry (Vaccinium angustifolium Aiton) juice exerted 
neurocognitive benefits measured by California Verbal Learning Test-II (CVLT) 
augmented associate learning and word-list recall in older adults of both sexes who 
had experienced age-related memory decline [145]. Similarly, randomized con-
trolled trial has shown that dietary berry juice (200 ml/day) for 12 weeks ameliorate 
memory and cognition in adults (70–80 years old) with cognitive impairment 
measured using a battery Rey Auditory Verbal Learning Test (RAVLT) [150].
Furthermore, a randomized, double-blind, placebo-controlled study showed 
that the daily administration of two capsules (10o mg) of a purified extract of 
blueberry (wild blueberry extract) for 3 months raised episodic and working 
memory in older adults of both sexes [151]. Additionally, a randomized, single-
blind, parallel group design showed that the acute consumption of 200 ml of wild 
blueberry drink (253 mg anthocyanins) in healthy children aged 7–10 years signifi-
cantly enhanced the memory and attentional aspects of executive function with 
respect to the placebo group 2 h after consumption; therefore, the consumption of 
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the wild blueberry drink during the critical period of development (as is the case of 
childhood) could provide acute cognitive benefits [152]. Therefore, a double-blind, 
counterbalanced, crossover intervention study showed that acute supplementation 
with haskap berry extract “Lonicera caerulea L.” (200 and 400 mg anthocyanins) 
raised the episodic memory and exerts benefits in cognitive performance following 
a single acute dose in older adults compared to placebo [153].
These findings support that the consumption of berries produces beneficial 
effects on cognition in humans, which are probably related to the effects of the 
berries on the nervous system. For example, blueberry diets are associated with 
enhanced working memory which is accompanied by an increase in the neurogenesis 
of the hippocampus [17]. A randomized, controlled, double-blind, crossover studio 
showed that the administration of 766 mg total blueberry polyphenols in healthy 
young men reduced neutrophil NADPH oxidase activity at 1, 2, 4, and 6 h after 
consumption [154]. In this sense, NADPH oxidase has been shown to play an impor-
tant role in oxidative stress induction in the brain [155], because it uses oxygen and 
NADPH to generate superoxide [156]. Therefore, the administration of blueberry 
could be generating a reduction of superoxide and indirectly preventing oxidative 
stress events a long term. The mechanisms by which flavonoids and polyphenols 
exert these actions on cognitive performance are still being studied, including 
evidence suggesting that they can increase brain blood flow, as well as modulate the 
activation state of neuronal receptors, signaling proteins, and gene expression [157].
6. Berry side or toxicity effect
According to our knowledge, there are some reports relating berry consump-
tion in humans with side effects or toxicity. Data of toxicity in vivo was reported 
in 1997, in a study of the relation between flavonoid intake and subsequent cancer 
risk in 9959 Finnish men and women, aged 15–99 years and who are initially cancer 
free. Food consumption and dietary history method calculated the consumption 
of lingonberries, blueberries, black currants, raspberries, and gooseberries. People 
with higher consumption of berries were found to have a high risk of lung cancer. 
Apparently, the phenolic compounds produce toxicity proliferating cancer cells, but 
are not toxic in healthy cells [49].
Another study of 5-weeks-old Swiss Webster male mice, supplemented with 
lyophilized nightshade berries (Solanum dulcamara, 8 g/kg) with two different 
stages of maturity, showed that immature fruit supplementation produced gastroin-
testinal lesions; however, this condition was not observed in mice administered with 
mature lyophilized fruit. The authors concluded that these effects were attributed 
to the presence of saponin in the immature fruit [158]. In 2015, the first toxicity 
report by Solanum dulcamara was reported in a dog puppy (Labrador Retriever); the 
toxicity was attributed to steroidal glycoalkaloid solanine. After causing vomiting to 
the dog, dried stems and immature berries were observed, and gastric contents were 
evaluated by a local botanist identifying Solanum dulcamara intake, concluding that 
dog poisoning was due to the consumption of this fruit [159].
Another report was in 2009, when dozens of dead cedar waxwings in Thomas 
County, Georgia, USA, were found. In this case report, after evaluating five birds, 
the investigation group observed pulmonary, mediastinal, and tracheal hemor-
rhages and also found berries (Nandina domestica Thunb.) intact and partly 
digested into the gastrointestinal tracts. Due to their voracious feeding behavior, 
these birds ingested toxic doses of N. domestica and at the same time high concen-
trations of cyanide present in fruit berry [160]. It is important to note that S. dulca-
mara and N. domestica species are found wildly and are not consumed by humans.
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Regarding berries supplementation and synergy, it is recently reported that 
gallic acid, quercetin, ellagic acid, and cyanidin have a market antioxidant activity 
[161, 162], due to the synergistic effects between the numbers of aromatic ring 
mixtures. In addition, polyphenols present in berries can interact between them, 
improve their antioxidant properties, and, therefore, increase human’s health 
benefits [162]. According to our knowledge, no studies were found related with 
pharmacological interactions and berry supplementation. It is necessary to carry 
out studies involving pharmacological molecules, berries’ activities, and their 
phenolic compounds in order to generate new therapies and identify the existence 
of side or toxic effects.
7. Final comments
According to the research reported in this chapter, the supplementation of 
berries and their bioactive compounds as flavonoids, polyphenols, and anthocyanin 
suggests a potential health benefit for human nutrition.
The objective of this research is to contribute with knowledge to the develop-
ment of new strategies for the treatment of diseases such as anxiety, depression, 
AD, and PD, which includes natural products, particularly berry fruits that work as 
preventive or coadjuvant therapy in the treatment of these diseases.
A further evaluation of fruits berry supplementation in neural processes is 
required, as well as the identification of the effect of each particular bioactive 
compound on psychiatric and neurological disorders. More studies will be neces-
sary to identify the mechanisms of action of this substance. It is also important to 
understand the scope in other neural processes and their application, effective-
ness, synergy, pharmacological interaction, and side or toxic effects at clinical and 
preclinical levels of studies.
8. Conclusions
The present chapter evidenced a number of investigations in vivo related with 
the use of different berry fruit supplement doses, not only in humans but also in 
animal models. These results suggest the potential health effect of berries due to 
bioactive compounds mainly flavonoids, polyphenols, and anthocyanins, used 
commonly for its antioxidant capacity. According to our knowledge, the cases 
reported in the literature by animal toxicity are related with the consumption of 
wild berries. In humans the relationship between phenol compound consumption 
and lung cancer has been reported; however, there is no evidence of side or toxic 
effects related with berry supplementation or their bioactive compounds, and phar-
macological interaction related to their consumption due to no dietary intervention 
studies has been reported.
In addition, berry consumption has shown to be effective in a number of car-
diovascular and metabolic diseases, and also recent investigations are proposed for 
the management of berry fruit supplementation as neuroprotector and the reduc-
tion of symptoms in diseases such as anxiety, depression, AD, and PD, among 
others. The use of this biological berry compounds might promote an alternative 
for prevention and give excellent opportunities for human nutrition as a functional 
food and nutraceutical. Future research in this field is necessary, in order to clarify 
and support the evidence of the effects of flavonoids, polyphenols, and anthocya-
nins at the brain level, as well as their potential direct and indirect mechanisms of 
action.
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